Deutsche Bank lowered the firm’s price target on Acadia Healthcare (ACHC) to $45 from $75 and keeps a Hold rating on the shares. The earnings report confirmed fears, and only time and a lack of headlines can return to the company to normalization, the analyst tells investors in a research note.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACHC:
- Acadia Healthcare Reports Strong Q3 2024 Results
- Closing Bell Movers: Microsoft, Meta both down about 3% despite earnings beats
- Acadia Healthcare cuts FY24 EPS view to $3.35-$3.45 from $3.45-$3.65
- Acadia Healthcare reports Q3 adjusted EPS 91c, consensus 90c
- Acadia options imply 10.0% move in share price post-earnings